Angiogenesis Assay Market

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

Angiogenesis Assay Market contains market size and forecasts of Angiogenesis Assay in Global, including the following market information:

Global Angiogenesis Assay Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Angiogenesis Assay market was valued at 19 million in 2021 and is projected to reach US$ 31 million by 2028, at a CAGR of 7.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

In Vitro Assay Kit Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Angiogenesis Assay include Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences and Sartorius (Essen BioScience) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Angiogenesis Assay companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Angiogenesis Assay Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Angiogenesis Assay Market Segment Percentages, by Type, 2021 (%)

In Vitro Assay Kit

In Vivo Assay Kit

Global Angiogenesis Assay Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Angiogenesis Assay Market Segment Percentages, by Application, 2021 (%)

Academic Institution

Biotech Companies

Global Angiogenesis Assay Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Angiogenesis Assay Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Angiogenesis Assay revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Angiogenesis Assay revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abcam

Bio-Techne

Thermo Fisher Scientific

Cell Biolabs, Inc.

BioVision, Inc

PromoCell GmbH

Merck KGaA

Kollodis BioSciences

Sartorius (Essen BioScience)

Creative Bioarray